These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1581879)
1. Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridization. McRobert TL; Rudduck C; Kees UR; Garson OM Cancer Genet Cytogenet; 1992 Apr; 59(2):128-34. PubMed ID: 1581879 [TBL] [Abstract][Full Text] [Related]
2. Three neuroblastoma cell lines established from consecutive samples of one patient which show distinct morphologic features, MYCN amplification, and surface marker expression. Kees UR; Ford J; Dawson VM; Ranford PR; Armstrong JA Cancer Genet Cytogenet; 1992 Apr; 59(2):119-27. PubMed ID: 1581878 [TBL] [Abstract][Full Text] [Related]
3. MYCN amplification and 17q in neuroblastoma: evidence for structural association. O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180 [TBL] [Abstract][Full Text] [Related]
4. Chromosomal localization of amplified N-myc in neuroblastoma cells using a biotinylated probe. Rudduck C; Lukeis RE; McRobert TL; Chow CW; Garson OM Cancer Genet Cytogenet; 1992 Jan; 58(1):55-9. PubMed ID: 1728951 [TBL] [Abstract][Full Text] [Related]
5. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Corvi R; Amler LC; Savelyeva L; Gehring M; Schwab M Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5523-7. PubMed ID: 8202521 [TBL] [Abstract][Full Text] [Related]
6. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Corvi R; Savelyeva L; Breit S; Wenzel A; Handgretinger R; Barak J; Oren M; Amler L; Schwab M Oncogene; 1995 Mar; 10(6):1081-6. PubMed ID: 7700632 [TBL] [Abstract][Full Text] [Related]
7. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line. Corvi R; Savelyeva L; Amler L; Handgretinger R; Schwab M Eur J Cancer; 1995; 31A(4):520-3. PubMed ID: 7576957 [TBL] [Abstract][Full Text] [Related]
8. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH. Pandita A; Godbout R; Zielenska M; Thorner P; Bayani J; Squire JA Genes Chromosomes Cancer; 1997 Nov; 20(3):243-52. PubMed ID: 9365831 [TBL] [Abstract][Full Text] [Related]
9. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Beheshti B; Braude I; Marrano P; Thorner P; Zielenska M; Squire JA Neoplasia; 2003; 5(1):53-62. PubMed ID: 12659670 [TBL] [Abstract][Full Text] [Related]
10. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma. Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues. Misra DN; Dickman PS; Yunis EJ Diagn Mol Pathol; 1995 Jun; 4(2):128-35. PubMed ID: 7551293 [TBL] [Abstract][Full Text] [Related]
12. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897 [TBL] [Abstract][Full Text] [Related]
13. Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma. Christiansen H; Franke F; Bartram CR; Adolph S; Rudolph B; Harbott J; Reiter A; Lampert F Cancer Genet Cytogenet; 1987 Jun; 26(2):235-44. PubMed ID: 3567877 [TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines. Van Roy N; Jauch A; Van Gele M; Laureys G; Versteeg R; De Paepe A; Cremer T; Speleman F Cancer Genet Cytogenet; 1997 Sep; 97(2):135-42. PubMed ID: 9283597 [TBL] [Abstract][Full Text] [Related]
15. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas. Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915 [TBL] [Abstract][Full Text] [Related]
17. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693 [TBL] [Abstract][Full Text] [Related]
19. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification. Souzaki R; Tajiri T; Teshiba R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T J Pediatr Surg; 2011 Dec; 46(12):2228-32. PubMed ID: 22152855 [TBL] [Abstract][Full Text] [Related]
20. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]